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ABSTRACT
IntroducƟ on: Menopause is the permanent cessaƟ on of menses resulƟ ng from reduced ovarian hormone 
secreƟ on that occurs naturally or is induced by surgery, chemotherapy, or radiaƟ on. Aims and objecƟ ves: 
To evaluate the risk of accelerated bone loss by assessing bone markers like alkaline phosphatase (ALP) and 
calcium in postmenopausal women. Material and methods: The present study was carried out on 100 total 
subjects out of which experimental group consists of 50 subjects i.e Post menopausal women. Control group 
consists of 50 subjects  Pre menopausal women. Results:  The result of the present study suggest that the 
serum calcium level were signifi cantly reduced but the serum alkaline phosphatase (ALP) levels had a slightly 
raise in post menopause group when compared to the pre menopause groups. Conclusion: In normal post 
menopausal women, an increase in bone turnover accelerates the reducƟ on in bone mass, whereas decrease 
in bone turnover is associated with preservaƟ on of bone mass.
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INTRODUCTION
The word ‘menopause’ is defi ned from the Greek words 
“meno” (month) and “paus’’ (to stop). Menopause is 
said to have occurred when menstruaƟ on has ceased 
for twelve months.1 Menopause is defined as the 
permanent cessaƟ on of menses resulƟ ng from reduced 
ovarian hormone secreƟ on that occurs naturally or is 
induced by surgery, chemotherapy, or radiaƟ on.2
 Post-menopause is an estrogens deficient state. It 
applies to the whole of a woman’s life aŌ er menopause.1 
Menopause and ageing is associated with accelerated 
loss of corƟ cal bone. Bone loss occurs when the balance 
between formaƟ on and resorpƟ on is upset and resorpƟ on 
is excessive resulƟ ng in a negaƟ ve remodelling balance.3 
Osteoporosis is an important public health problem in 
older adults. It is more common in postmenopausal 
women and not only gives rise to morbidity but also 
markedly diminishes the quality of life in this populaƟ on. 
There is lack of informaƟ on about the risk factor of 
osteoporosis in developing countries.4 Serum alkaline 
phosphatase is the most commonly used marker of bone 
formaƟ on. ALP is a ubiquitous enzyme that plays an 
important role in osteoid formaƟ on and mineralizaƟ on. 
The total ALP serum pool consists of several dimeric 
isoforms which originate from various Ɵ ssues such as 
liver, bone, intesƟ ne, spleen, kidney and placenta.5
Menopause is the permanent cessaƟ on of menstruaƟ on 
due to loss of ovarian follicular function, which 
results in decreased production of estradial and 
other hormones. Decreased levels of estrogen leads 
to increased osteoclast formationl and enchanced 
bone resorpƟ on, which inturn leads to loss of bone 
density and destrucƟ on of local architecture resulƟ ng 
in microfractures.6
AIM OF THE STUDY:
To evaluate the risk of accelerated bone loss by assessing 
bone markers like alkaline phosphatase (ALP) and 
calcium in postmenopausal women.
MATERIALS AND METHODS 
The present study was carried out on 100 total subjects 
out of which experimental group consists of 50 subjects 
i.e Post menopausal women. Control group consists of 
50 subjects  Pre menopausal women. 
A total 50 post menopausal subjects were recruited 
for the study with the age group of >45 years for 
experimental group. Exclusion criteria were smokers, 
alcoholics and calcium supplement. A total 50 pre 
menopausal subjects were recruited for the study with 
the age group of 12-40 years for control group. Exclusion 
criteria were Pregnancy, Smokers, Alcoholics and Oral 
contracepƟ ves.          
RESULTS
The present study analyse the serum calcium level and 
ALP level in post menopausal women and compared 
with the pre menopausal women. The study was 
carried out on two groups of populaƟ on, experimental 
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group i.e. post menopausal women consisting of 
50 females and control group i.e. pre menopausal 
women consisƟ ng of 50 females. Exclusion criteria 
include smoking, consumpƟ on of alcohol, pregnancy, 
oral contraceptive administration and calcium 
supplementaƟ on.
Table 1: Comparison of mean values of Ca (mg/dl) and ALP (U/L) 
between Post and Pre  Menopausal women
Variable
Post Menopausal Pre Menopausal
Mean SD Mini Max Mean SD Mini Max
Ca  mg/dl   8.73 0.60 5.50 9.40 9.65 0.68 9.00 13.50
ALP U/L     111.86 66.56 41.00 414.00 82.40 78.50 21.00 550.00
    
Table 2:   Test of signifi cance of mean values of Ca and ALP 
between post and Pre Menopausal women.
Variable Post menopausal Pre menopausal P t  
Ca mg/dl 8.73 9.65 0.000 7.09*
ALP U/L 111.86 82.4 0.046 2.03*
*indicates 5 % level of signifi cance        
Table 1 and 2: shows that serum calcium were signifi cantly 
reduced in post menopause group mean (8.73±0.60) 
when compared to the pre menopause group  mean 
(9.65±0.68) which shows a strong signifi cant of p=0.000, 
but both group values were within the normal reference 
range. Where as serum alkaline phosphatase (ALP) 
levels had a slight raise in post menopause group mean 
(111.86±66.5) when compared to the pre menopause 
group (82.40±78.50) showing  only 5% signifi cant with 
p= 0.046, in these group also the values fall in the 
normal reference range. 
Table 3:  shows a signifi cant negaƟ ve co relaƟ on between 
calcium and Alkaline phosphatase (r= -0.1496), where in 
serum Alkaline phosphatase levels are elevated whereas 
serum calcium levels are reduced in postmenopausal 
women.
Table 3: Pearson correlaƟ on coeffi  cient of serum calcium and 
serum ALP levels in post menopausal women.
CorrelaƟ on Coeffi  cient
Case
(n=50)
r value between  calcium and ALP in 
post menopausal women
-0.1496
Correlation coeffi cient between post Ca and post ALP = - 0.1496 
DISCUSSION
Menopause is associated with numerous physiological 
and biochemical changes affecting bone mineral 
metabolism. Results from various case control study 
on esƟ maƟ on of serum calcium, inorganic phosphate, 
total proteins, albumin, alkaline phosphatase and acid 
phosphatise activities in pre and post menopausal 
women have shown that serum calcium levels of post 
menopausal women is not staƟ sƟ cally signifi cant. This is 
in accordance with the fi ndings of Ashuma , Suresh and 
Naidu and Masse et.al who also reported higher levels 
of these parameters in post menopausal women.7-9 
In the present study we had signifi cance in case and 
control means but sƟ ll the values tend to remain in 
normal reference range. The serum calcium were 
signifi cantly reduced in post menopause group mean 
(8.73±0.60) when compared to the pre menopause 
group mean (9.65±0.68) which shows a strong signifi cant 
of p=0.000. Where as serum alkaline phosphatase (ALP) 
levels had a sight raise in post menopause group mean 
(111.86±66.5) when compared to the pre menopause 
group (82.40±78.50) showing  only 5% signifi cant with p= 
0.046. Ashuma et.al, said that ageing and menopause, 
leads to decline in estrogen and progesterone producƟ on 
which has been implicated in the increased levels of 
calcium in post menopausal women.7 It is well known 
that estrogen defi ciency induces synthesis of cytokines 
by osteoblast, monocytes and T cells and thereby 
sƟ mulates bone resorpƟ on by increasing osteoclasƟ c 
acƟ vity. This results in modifi caƟ on of the reabsorpƟ on, 
excreƟ on and resorpƟ on of calcium leading to increased 
circulaƟ ng levels of this ion.10-12
No signifi cant variaƟ on was observed in serum levels of 
calcium and ALP in the various years since menopause 
group (YSM). However contrary to this fi nding higher 
calcium and ALP have been demonstrated in early 
post menopausal women (≤10 YSM) compared to late 
menopausal women (≤10 YSM).13
Bone is a connecƟ ve Ɵ ssue that provides mechanical 
support to the body vital organs and act as reservoir of 
calcium and phosphate as 99% of calcium and 85% of 
phosphate are present in skeleton. Peak bone mass is 
achieved during the third decade of life which gradually 
declines leading to osteopenia which predisposes to 
osteoporosis14.
CONCLUSION
In normal post menopausal women, an increase in 
bone turnover accelerates the reducƟ on in bone mass, 
whereas decrease in bone turnover is associated with 
preservaƟ on of bone mass. In our present study serum 
calcium level and ALP levels were esƟ mated in post 
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menopausal women were esƟ mated and compared 
with pre menopausal women. 
The comparison study reveals that the serum calcium 
were signifi cantly reduced in post menopause group 
mean when compared to the pre menopause group 
mean which shows a strong signifi cant of p=0.000. 
Whereas serum alkaline phosphatase (ALP) levels had 
a slightly raised in post menopause group mean when 
compared to the pre menopause group showing only 
5% signifi cant with p= 0.046. A signifi cant negaƟ ve 
correlaƟ on was observed between serum calcium and 
ALP levels in postmenopausal experimental women
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